ArticleFrontiers in immunology2026

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Michaela Feodoroff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.